- Home
- HOUS vs SAGE Comparison
HOUS vs SAGE Comparison
Compare HOUS & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUS
- SAGE
- Stock Information
- Founded
- HOUS 2006
- SAGE 2010
- Country
- HOUS United States
- SAGE United States
- Employees
- HOUS N/A
- SAGE N/A
- Industry
- HOUS Real Estate
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- HOUS Finance
- SAGE Health Care
- Exchange
- HOUS Nasdaq
- SAGE Nasdaq
- Market Cap
- HOUS 445.0M
- SAGE 444.1M
- IPO Year
- HOUS 2006
- SAGE 2014
- Fundamental
- Price
- HOUS $3.72
- SAGE $7.31
- Analyst Decision
- HOUS Sell
- SAGE Hold
- Analyst Count
- HOUS 3
- SAGE 20
- Target Price
- HOUS $5.33
- SAGE $10.67
- AVG Volume (30 Days)
- HOUS 713.4K
- SAGE 1.7M
- Earning Date
- HOUS 02-13-2025
- SAGE 02-11-2025
- Dividend Yield
- HOUS N/A
- SAGE N/A
- EPS Growth
- HOUS N/A
- SAGE N/A
- EPS
- HOUS N/A
- SAGE N/A
- Revenue
- HOUS $5,692,000,000.00
- SAGE $41,243,000.00
- Revenue This Year
- HOUS $8.38
- SAGE $123.13
- Revenue Next Year
- HOUS $7.34
- SAGE $69.65
- P/E Ratio
- HOUS N/A
- SAGE N/A
- Revenue Growth
- HOUS 0.99
- SAGE N/A
- 52 Week Low
- HOUS $2.71
- SAGE $4.62
- 52 Week High
- HOUS $6.40
- SAGE $23.22
- Technical
- Relative Strength Index (RSI)
- HOUS 51.64
- SAGE 60.55
- Support Level
- HOUS $3.62
- SAGE $7.00
- Resistance Level
- HOUS $4.07
- SAGE $7.26
- Average True Range (ATR)
- HOUS 0.25
- SAGE 0.19
- MACD
- HOUS 0.03
- SAGE -0.06
- Stochastic Oscillator
- HOUS 48.53
- SAGE 57.14
About HOUS Anywhere Real Estate Inc.
Anywhere Real Estate Inc operates in residential real estate, focusing on brokerage, relocation, title, settlement businesses, and mortgage and title insurance ventures. It supports approximately 1 million home sale sides annually. Brands include Better Homes and Gardens, CENTURY 21, Coldwell Banker, Corcoran, ERA, and Sotheby's International Realty. Revenue comes mainly from existing home transactions. Operations are segmented into Anywhere Brands (franchises), Anywhere Advisors (owned brokerage), and Anywhere Integrated Services (title and settlement).
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.